Circulating cytokine concentrations in tuberculosis and other chronic bacterial infections

Infection

Volumn 27, Issue 4-5, 1999, Pages 272-274

  Poveda, F ^a   Camacho, J ^b   Arnalich, F ^b   Codoceo, R ^b   Del Arco, A ^a   Martinez Hernandez P ^b  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL INFECTION; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS;

ADULT; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PROBABILITY; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032881911     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100050028     Document Type: Article

References (16)

1. Ellner, J. J.: Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med. 130 (1997) 469-475.
2. Munk, M. E., Emoto, M.: Functions of T-cell subsets and cytokines in mycobacterial infections. Eur. Resp. J. 8 (Suppl. 20) (1995) 668S-675S.
3. Orme, I. M., Andersen, P., Boom, W. H.: T-cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167 (1993) 1481-1497.
4. Rom, W. N., Schluger, N., Law, K., Condos, R., Zhang, Y., Weiden, M.: Human host response to Mycobacterium tuberculosis. Schweiz. Med. Wochenschr. 125 (1995) 2178-2185.
5. Shijubo, N., Imai, K., Nakanishi, F., Yachi, A., Abe, S.: Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis. Am. Rev. Respir. Dis. 148 (1993) 1289-1301.
6. Friedland, J. S., Hartley, J. C., Hartley, C. G., Shattock, R. J., Griffin, G. E.: Cytokine secretion in vivo and ex vivo following chemotherapy of Mycobacterium tuberculosis infection. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 199-203.
7. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., Bloom, B. R.: An essential role of IFN-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178 (1993) 2249-2254.
8. Barnes, P. F., Lu, S., Abrams, J. S., Wang, E., Yamamura, M., Modlin, R. L.: Cytokine production at the site of disease in human tuberculosis. Infect. Immunol. 61 (1993) 3482-3489.
9. Lin, Y., Zhang, M., Hofman, F. M., Gong, J., Barnes, P. F.: Absence of a prominent Th2 cytokine response in human tuberculosis. Infect. Immunol. 64 (1996) 1351-1356.
10. Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R.: A mutation in the interferon-(gamma)-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335 (1996) 1941-1949.
11. Di Piro, J. T.: Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 17 (1997) 205-223.
12. Flesch, I., Kaufmann, S. H.: Mycobacterial growth inhibition by interferon-activated bone marrow macrophages and differential susceptibility amongst strains of Mycobacterium tuberculosis. J. Immunol. 138 (1987) 4408-4413.
13. Rook, G. A., Champion, B. R., Steele, J., Varey, A. M., Stanford, J. L.: A restricted activation by T cell lines of anti-tuberculous activity in murine macrophages. Clin. Exp. Immunol. 159 (1985) 414-420.
14. Douvas, G. S., Looker, D. L., Vatter, A. E., Crowle, A. J.: Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macro-phage-associated mycobacteria. Infect. Immun. 50 (1985) 1-8.
15. Altare, F., Durandy, A., Lammas, D., Emile, J. F., Lamhamedi, S., Deist, F.: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280 (1998) 1432-1435.
16. Holland, S. M., Eisenstein, E. M., Kuhns, D. B.: Treatment of refractory disseminated nontuberculous infection with interferon gamma: a preliminary report. N. Engl. J. Med. 330 (1994) 1348-1355.